Immuno-fluorescence microscopy demonstrated that tHBcAg VLNP displaying the CPP successfully delivered the nanoparticle into A431, HT29 and HeLa cells in EGFR-dependent manner, which paves the way for the application of the CPP to deliver VLNPs to cancer cells overexpressing EGFR. This evidence concerns the gene EGFR and cancer.